AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Glytas-MF Tablet

Prescription Icon
Prescription Required

Marketer

Tas Med India Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glytas-MF Tablet

DiaBeta-Duo tablets are classified as antidiabetic medications, combining two agents to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. DiaBeta-Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's a component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and trembling; constipation; and vomiting. Regular meals and readily available fast-acting glucose (e.g., sugary snacks or juice) are essential to mitigate hypoglycemia. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional potential side effects encompass altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, upper respiratory infections, and weight gain. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or lactating women require physician consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to assess blood cell counts and liver function.

Uses of Glytas-MF Tablet

Diabetes mellitus type 2

Major Benefits of Glytas-MF Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glytas-MF Tablet with a meal.

Common Side effects of Glytas-MF Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glytas-MF Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glytas-MF Tablet with a meal.

How Glytas-MF Tablet works:

Glytas-MF tablets contain gliclazide and metformin, two medications used to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption while taking Glytas-MF Tablets is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glytas-MF tablets during pregnancy poses a known risk to the fetus. Therefore, it's contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the inherent dangers. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Glytas-MF tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glytas-MF Tablet cautiously, potentially requiring dosage modification under medical supervision. Glytas-MF Tablet is contraindicated in those with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glytas-MF tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate hepatic dysfunction, Glytas-MF tablets are typically initiated at a low dosage; however, their use is contraindicated in individuals with severe liver disease.

What if you forget to take Glytas-MF Tablet :

Should you forget a Glytas-MF Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glytas-MF Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glytas-MF Tablet

Glytas-MF tablets combine gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glytas-MF is not suitable for type 1 DM.
Glytas-MF Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glytas-MF Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glytas-MF Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). While rare, this side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glytas-MF and seek immediate medical attention.
Prolonged Glytas-MF Tablet use can lead to vitamin B12 deficiency by impairing its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glytas-MF Tablets are contraindicated in patients with hypersensitivity to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glytas-MF tablets and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glytas-MF tablets combine gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glytas-MF is not suitable for type 1 DM.
Glytas-MF Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glytas-MF Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glytas-MF Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This is a rare side effect, but it's crucial to avoid use in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Glytas-MF and seek immediate medical attention.
Prolonged Glytas-MF Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Glytas-MF Tablets are contraindicated in patients with hypersensitivity to any ingredient or excipient. Their use is also contraindicated in patients with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glytas-MF tablets and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glytas-MF Tablet
61
MRP 74
18% off